Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Receivables (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Change in Receivables for 15 consecutive years, with -$20.7 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Receivables fell 364.11% year-over-year to -$20.7 million; the TTM value through Mar 2026 reached -$22.7 million, down 7657.14%, while the annual FY2025 figure was $5.8 million, 54.8% down from the prior year.
  • Change in Receivables hit -$20.7 million in Q1 2026 for Corcept Therapeutics, down from -$9.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $20.4 million in Q1 2024 and bottomed at -$20.7 million in Q1 2026.
  • Average Change in Receivables over 5 years is $673352.9, with a median of $1.5 million recorded in 2023.
  • On a YoY basis, Change in Receivables climbed as much as 1259.67% in 2024 and fell as far as 191925.0% in 2024.
  • Corcept Therapeutics' Change in Receivables stood at $1.6 million in 2022, then soared by 295.44% to $6.5 million in 2023, then plummeted by 188.36% to -$5.7 million in 2024, then plummeted by 71.45% to -$9.8 million in 2025, then crashed by 110.44% to -$20.7 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$20.7 million, -$9.8 million, and $5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.